<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02607267</url>
  </required_header>
  <id_info>
    <org_study_id>FF 83/2015</org_study_id>
    <nct_id>NCT02607267</nct_id>
  </id_info>
  <brief_title>Edmonton Obesity Staging System: Post-operative Outcome and 30-day Mortality</brief_title>
  <official_title>The Importance of the Edmonton Obesity Score System in Predicting Postoperative Outcome and 30 Day Mortality After Metabolic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sana Klinikum Offenbach</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sana Klinikum Offenbach</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Edmonton Obesity Staging System (EOSS) is a more comprehensive measure of obesity-related
      diseases and predictor of mortality than BMI or waist circumference. The aim of this study is
      to determine whether the EOSS is also important in predicting post - operative outcome and
      30-day mortality after metabolic surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      From October 2014 to December 2015 the investigators conducted a prospective data collection
      on patients undergoing either laparoscopic sleeve gastrectomy (LSG) or laparoscopic Gastric
      Bypass (Laparoscopic Roux-en-Y-Gastric Bypass (LRYGB) and Omega-Loop-Gastric-Bypass (LOLGB)),
      being the first surgical treatment for severe obesity. Preoperative EOSS by Sharma et al. was
      applied to all patients by two different evaluators. Data collection included the following:
      gender, age, body mass index, waist circumference, waist to hip ratio, comorbidities, early -
      postoperative complications, readmission rates and 30 - day mortality. Follow-up was
      performed in all patients up to 1 month after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative outcome related to EOSS</measure>
    <time_frame>30 days after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative complications related to EOSS</measure>
    <time_frame>30 days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>readmission rates related to EOSS</measure>
    <time_frame>30 days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>age related to postoperative complications</measure>
    <time_frame>30 days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BMI related to postoperative complications</measure>
    <time_frame>30 days after surgery</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">534</enrollment>
  <condition>Postoperative Complications</condition>
  <condition>Other Complications of Other Bariatric Procedure</condition>
  <arm_group>
    <arm_group_label>laparoscopic Roux en Y Gastric Bypass</arm_group_label>
    <description>patients undergoing LRYGB, being the first surgical treatment for severe obesity</description>
  </arm_group>
  <arm_group>
    <arm_group_label>laparoscopic Sleeve Gastrectomy</arm_group_label>
    <description>patients undergoing LSG, being the first surgical treatment for severe obesity</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>LSG and LRYGB</intervention_name>
    <description>The role of the Edmonton Obesity Staging System in predicting post-operative outcome and 30-day mortality after metabolic surgery (LSG and LRYGB)</description>
    <arm_group_label>laparoscopic Roux en Y Gastric Bypass</arm_group_label>
    <arm_group_label>laparoscopic Sleeve Gastrectomy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing either LSG, LRYGB or LOLGB, being the first surgical treatment for
        severe obesity
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing either LSG or LRYGB, being the first surgical treatment for severe
             obesity

        Exclusion Criteria:

          -  bariatric surgery in the anamnesis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>73 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christine Stier, MD</last_name>
    <role>Study Director</role>
    <affiliation>Sana Klinikum Offenbach</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sana Klinikum Offenbach</name>
      <address>
        <city>Offenbach am Main</city>
        <state>Hessen</state>
        <zip>63069</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Kuk JL, Ardern CI, Church TS, Sharma AM, Padwal R, Sui X, Blair SN. Edmonton Obesity Staging System: association with weight history and mortality risk. Appl Physiol Nutr Metab. 2011 Aug;36(4):570-6. doi: 10.1139/h11-058. Epub 2011 Aug 14.</citation>
    <PMID>21838602</PMID>
  </reference>
  <reference>
    <citation>Padwal RS, Pajewski NM, Allison DB, Sharma AM. Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ. 2011 Oct 4;183(14):E1059-66. doi: 10.1503/cmaj.110387. Epub 2011 Aug 15.</citation>
    <PMID>21844111</PMID>
  </reference>
  <reference>
    <citation>Gill RS, Karmali S, Sharma AM. The potential role of the Edmonton obesity staging system in determining indications for bariatric surgery. Obes Surg. 2011 Dec;21(12):1947-9. doi: 10.1007/s11695-011-0533-8. Review.</citation>
    <PMID>22002510</PMID>
  </reference>
  <results_reference>
    <citation>Sharma AM, Kushner RF. A proposed clinical staging system for obesity. Int J Obes (Lond). 2009 Mar;33(3):289-95. doi: 10.1038/ijo.2009.2. Epub 2009 Feb 3. Review.</citation>
    <PMID>19188927</PMID>
  </results_reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 16, 2015</study_first_submitted>
  <study_first_submitted_qc>November 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2015</study_first_posted>
  <last_update_submitted>April 24, 2018</last_update_submitted>
  <last_update_submitted_qc>April 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sana Klinikum Offenbach</investigator_affiliation>
    <investigator_full_name>Sonja Chiappetta, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>EOSS</keyword>
  <keyword>Metabolic Surgery</keyword>
  <keyword>postoperative outcome</keyword>
  <keyword>30 - day mortality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

